- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Artis (101140)
Track today's live InBioGen Co Ltd (101140) share price, performance and key data on this page with our current Seoul:101140 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the InBioGen Co Ltd share price on the Seoul exchange. Use the dropdown to switch exchange for the 101140 share price, head to our technical summary section, which provides analysis on InBioGen Co Ltd share price buy/sell indicators using real-time data (or discuss the InBioGen Co Ltd (101140) stock price today with other investors in the InBioGen Co Ltd KS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KS:101140 share price (ISIN: KR7101140002) to enhance your trading decisions with our free investment tools and resources.
What Is the Artis Share Price Today?
The InBioGen Co Ltd share price today is 4,890.
What Is the Stock Symbol for Artis
The stock symbol (or 'ticker') for InBioGen Co Ltd is "101140."
What Stock Exchange Does Artis Trade On?
InBioGen Co Ltd is listed and trades on the Seoul stock exchange.
Is Artis a Good Stock to Buy?
Determining whether InBioGen Co Ltd (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KS:101140 share price (ISIN: KR7101140002) to enhance your trading decisions with our free investment tools and resources.
What Is the Artis Share Price Today?
The InBioGen Co Ltd share price today is 4,890.
What Is the Stock Symbol for Artis
The stock symbol (or 'ticker') for InBioGen Co Ltd is "101140."
What Stock Exchange Does Artis Trade On?
InBioGen Co Ltd is listed and trades on the Seoul stock exchange.
Is Artis a Good Stock to Buy?
Determining whether InBioGen Co Ltd (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Seoul
Currency in KRW
4,890
-95(-1.91%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4,705
5,010
52 wk Range
4,705
14,300
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4,7055,010
52 wk Range
4,70514,300
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
101140 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
30/07/2026
EPS / Forecast
-147.77 / --
Revenue / Forecast
1.51B / --
Compare 101140 to Peers and Sector
Metrics to compare | 101140 | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship Relationship101140PeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.3x | −0.4x | 9.9x | |
PEG Ratio | 0.01 | 0.02 | 0.02 | |
Price/Book | 0.3x | 0.3x | 1.4x | |
Price / LTM Sales | 9.3x | 0.3x | 0.9x | |
Upside (Analyst Target) | - | 60.9% | 32.9% | |
Fair Value Upside | Unlock | 21.6% | 12.9% | Unlock |
INBIOGEN Co., Ltd. engages in the manufacture and distribution of footwear products in South Korea. It is also involved in distribution of wood pellets; kiosk; and food and beverage businesses. The company was formerly known as BTONE CO.,Ltd. INBIOGEN Co., Ltd. was founded in 1949 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the InBioGen Co Ltd (Seoul: 101140) Share Price Today?
The InBioGen Co Ltd stock price today is 4,890 KRW.
What Stock Exchange Does InBioGen Co Ltd (101140) Trade On?
InBioGen Co Ltd is listed and trades on the Seoul Stock Exchange.
What Is the Ticker (Stock Symbol) for InBioGen Co Ltd?
The stock symbol (also called a 'ticker') for InBioGen Co Ltd is "101140."
What Is the Current InBioGen Co Ltd Market Capitalisation?
As of today, InBioGen Co Ltd (Seoul: 101140) market cap is 48.83B KRW.
What Is InBioGen Co Ltd's (101140) Earnings Per Share (TTM)?
The InBioGen Co Ltd EPS is currently -2,076 (Trailing Twelve Months).
Is 101140 a Buy or Sell From a Technical Analyst Perspective?
Based on today's InBioGen Co Ltd moving averages and other technical indicators, the daily buy/sell signal for 101140 stock is Strong Sell.
How Many Times Has InBioGen Co Ltd Stock Split?
InBioGen Co Ltd has split 7 times. (See the 101140 stock split history page for full effective split date and price information.)
How Many Employees Does InBioGen Co Ltd Have?
InBioGen Co Ltd has 41 employees, based on their latest Companies House report.
What is the current trading status of InBioGen Co Ltd (Seoul: 101140)?
As of 17/09/2026, InBioGen Co Ltd (101140) is trading at a share price of 4,890 KRW, with a previous close of 4,890 KRW. The stock has fluctuated within a day range of 4,705 KRW to 5,010 KRW, while its 52-week range spans from 4,705 KRW to 14,300 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.